Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method

Annals of Thoracic Surgery

Volumn 67, Issue 1, 1999, Pages 79-84

  Kawahito, Koji ^a   Kobayashi, Eiji ^a   Iwasa, Hideaki ^a   Misawa, Yoshio ^a   Fuse, Katsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEMODILUTION; HUMAN; LASER; LIGHT SCATTERING; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION;

ADULT; AGED; BLOOD PLATELETS; CARDIOPULMONARY BYPASS; CELL SIZE; FEMALE; HEART DISEASES; HUMANS; LASERS; MALE; MIDDLE AGED; PLATELET AGGREGATION; POSTOPERATIVE PERIOD;

EID: 0033060018     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00821-2     Document Type: Article

References (23)

1. Mohr R, Golan M, Martinowitz U, Rosner E, Goor DA, Ramot B. Effect of cardiac operation on platelets. J Thorac Cardiovasc Surg 1986;92:434-41.
2. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Haemost 1985;11:281-92.
3. Ray MJ, Hawson GAT, Just SJE, McLachlan G, O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6.
4. Edmunds LH Jr, Ellison N, Colman RW, et al. Platelet function during cardiac operation. Comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982;83:805-12.
5. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
6. O'Brien JR. Shear-induced platelet aggregation. Lancet 1990; 335:711-3.
7. Tabuchi N, Gallandat Huet RCG, Sturk A, Eijsman L, Wildevuur CRH. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway. J Thorac Cardiovasc Surg 1995;110:813-8.
8. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17.
9. Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995;60:1008-14.
10. Lindblad B, Wakefield TW, Whitehouse WM Jr, Stanley JC. The effect of protamine sulfate on platelet function. Scand J Thorac Cardiovasc Surg 1988;22:55-9.
11. Born GVR. Observation on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 1970;209:487-511.
12. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980;3:135-58.
13. Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11-8.
14. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991;75:388-93.
15. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218:284-94.
16. Yamamoto T, Egawa Y, Shirasawa Y, et al. A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 1995;6:174-80.
17. Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y. Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 1996;75:838-43.
18. Lentz WJ. Generating Bessel function in Mie scattering calculation using continued fractions. Appl Opt 1976;15: 668-71.
19. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993;106:1-10.
20. Friedenberg WR, Myers WO, Plotka ED, et al. Platelet dysfunction associated with cardiopulmonary bypass. Ann Thorac Surg 1978;25:298-305.
21. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
22. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 1989;97: 379-88.
23. Primack C, Walenga JM, Koza MJ, Shankey TV, Pifarré R. Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations. Ann Thorac Surg 1996;61:1188-93.